Compare MRM & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRM | GXAI |
|---|---|---|
| Founded | 2000 | 2021 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 14.2M |
| IPO Year | 2020 | 2023 |
| Metric | MRM | GXAI |
|---|---|---|
| Price | $1.34 | $1.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 49.8K | ★ 16.2M |
| Earning Date | 05-22-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $55,915,220.00 | $694,278.00 |
| Revenue This Year | N/A | $42,959.35 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | $31.54 | ★ N/A |
| Revenue Growth | 12.79 | ★ 23205.74 |
| 52 Week Low | $0.34 | $1.00 |
| 52 Week High | $4.45 | $2.96 |
| Indicator | MRM | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 17.53 | 45.23 |
| Support Level | $1.21 | $1.31 |
| Resistance Level | $1.73 | $2.63 |
| Average True Range (ATR) | 0.09 | 0.30 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 23.02 | 4.87 |
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.